Skip to main content
SpringerLink
Log in

Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases

  • Chapter
  • First Online:
Cancer Screening in Inflammatory Bowel Disease

Abstract

Colorectal cancer (CRC) is a dreaded complication of inflammatory bowel disease (IBD), accounting for up to 15% of IBD-related deaths. Chronic or recurrent mucosal inflammation leads to widespread genetic mutations within colitic mucosa, increasing CRC risk in IBD patients. Pooled risk estimates for CRC risk among IBD patients range between 1.5- and 2-fold higher than background risk across meta-analyses of population-based studies and 4- and 6-fold higher than background risk in meta-analyses of referral center studies. Paralleling CRC risk, the mortality risk from CRC in IBD patients has ranged between 1.2- and 2-fold higher than background across population-based studies. European studies have reported declining CRC risk over time, whereas North American studies have reported stable CRC risk among IBD patients, compared with persons in the general population. Risk factors for CRC in IBD patients include increasing age, longer duration of disease, greater extent of colitis, greater disease severity, and the presence of primary sclerosing cholangitis. IBD-associated CRC affects patients at a younger age than sporadic CRC, leading to a higher relative risk of CRC among younger patients with IBD as compared with younger persons without IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18(Suppl 2):1–5.

    Article  Google Scholar 

  2. Murthy S, Flanigan A, Clearfield H. Colorectal cancer in inflammatory bowel disease: molecular and clinical features. Gastroenterol Clin N Am. 2002;31:551–64, x.

    Article  Google Scholar 

  3. Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol. 2008;14:2662–9.

    Article  Google Scholar 

  4. Rhodes JM, Campbell BJ. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med. 2002;8:10–6.

    Article  CAS  Google Scholar 

  5. Rutter MD. Importance of nonpolypoid (flat and depressed) colorectal neoplasms in screening for CRC in patients with IBD. Gastrointest Endosc Clin N Am. 2014;24:327–35.

    Article  Google Scholar 

  6. Tytgat GN, Dhir V, Gopinath N. Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease. Eur J Cancer. 1995;31A:1174–7.

    Article  CAS  Google Scholar 

  7. Low D, Mino-Kenudson M, Mizoguchi E. Recent advancement in understanding colitis-associated tumorigenesis. Inflamm Bowel Dis. 2014;20:2115–23.

    Article  Google Scholar 

  8. Matkowskyj KA, Chen ZE, Rao MS, Yang GY. Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology. Arch Pathol Lab Med. 2013;137:338–50.

    Article  CAS  Google Scholar 

  9. Rubio CA, Slezak P. The unique pathology of nonpolypoid colorectal neoplasia in IBD. Gastrointest Endosc Clin N Am. 2014;24:455–68.

    Article  Google Scholar 

  10. Lofberg R, Brostrom O, Karlen P, Ost A, Tribukait B. DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology. 1992;102:1149–54.

    Article  CAS  Google Scholar 

  11. Lyda MH, Noffsinger A, Belli J, Fischer J, Fenoglio-Preiser CM. Multifocal neoplasia involving the colon and appendix in ulcerative colitis: pathological and molecular features. Gastroenterology. 1998;115:1566–73.

    Article  CAS  Google Scholar 

  12. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103:1611–20.

    Article  CAS  Google Scholar 

  13. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994;343:71–4.

    Article  CAS  Google Scholar 

  14. Connell WR, Talbot IC, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut. 1994;35:1419–23.

    Article  CAS  Google Scholar 

  15. Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Granqvist S. Twenty years’ colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand J Gastroenterol. 1996;31:1195–204.

    Article  CAS  Google Scholar 

  16. Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25:657–68.

    Article  CAS  Google Scholar 

  17. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–89.

    Article  Google Scholar 

  18. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–45.

    Article  Google Scholar 

  19. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314–21.

    Article  Google Scholar 

  20. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501–23.

    Article  Google Scholar 

  21. Leddin D, Hunt R, Champion M, et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: guidelines on colon cancer screening. Can J Gastroenterol. 2004;18:93–9.

    Article  Google Scholar 

  22. Adami HO, Bretthauer M, Emilsson L, et al. The continuing uncertainty about cancer risk in inflammatory bowel disease. Gut. 2016;65:889–93.

    Article  CAS  Google Scholar 

  23. Castano-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther. 2014;39:645–59.

    Article  CAS  Google Scholar 

  24. Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724–9.

    Article  Google Scholar 

  25. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–45.

    Article  Google Scholar 

  26. Laukoetter MG, Mennigen R, Hannig CM, et al. Intestinal cancer risk in Crohn’s disease: a meta-analysis. J Gastrointest Surg. 2011;15:576–83.

    Article  Google Scholar 

  27. Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19:789–99.

    Article  Google Scholar 

  28. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.

    Article  CAS  Google Scholar 

  29. Gilat T, Fireman Z, Grossman A, et al. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology. 1988;94:870–7.

    Article  CAS  Google Scholar 

  30. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006;130:1039–46.

    Article  Google Scholar 

  31. Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13:481–9.

    Article  Google Scholar 

  32. Palli D, Trallori G, Bagnoli S, et al. Hodgkin’s disease risk is increased in patients with ulcerative colitis. Gastroenterology. 2000;119:647–53.

    Article  CAS  Google Scholar 

  33. Rutegard JN, Ahsgren LR, Janunger KG. Ulcerative colitis. Colorectal cancer risk in an unselected population. Ann Surg. 1988;208:721–4.

    Article  CAS  Google Scholar 

  34. Soderlund S, Brandt L, Lapidus A, et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009;136:1561–7.

    Article  Google Scholar 

  35. Stewenius J, Adnerhill I, Anderson H, et al. Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmo, Sweden. Int J Color Dis. 1995;10:117–22.

    Article  CAS  Google Scholar 

  36. Wandall EP, Damkier P, Moller Pedersen F, Wilson B, Schaffalitzky de Muckadell OB. Survival and incidence of colorectal cancer in patients with ulcerative colitis in Funen county diagnosed between 1973 and 1993. Scand J Gastroenterol. 2000;35:312–7.

    CAS  PubMed  Google Scholar 

  37. Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Intestinal and extra-intestinal cancer in Crohn’s disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther. 2004;19:287–93.

    Article  CAS  Google Scholar 

  38. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854–62.

    Article  CAS  Google Scholar 

  39. Winther KV, Jess T, Langholz E, Munkholm P, Binder V. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol. 2004;2:1088–95.

    Article  Google Scholar 

  40. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228–33.

    Article  CAS  Google Scholar 

  41. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet. 1990;336:357–9.

    Article  CAS  Google Scholar 

  42. Baars JE, Looman CW, Steyerberg EW, et al. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol. 2011;106:319–28.

    Article  Google Scholar 

  43. Jess T, Simonsen J, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–81.

    Article  Google Scholar 

  44. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–8.

    Article  Google Scholar 

  45. Hoie O, Wolters FL, Riis L, et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology. 2007;132:507–15.

    Article  Google Scholar 

  46. Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009;58:1490–7.

    Article  CAS  Google Scholar 

  47. Benchimol EI, Guttmann A, Mack DR, et al. Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada. J Clin Epidemiol. 2014;67:887–96.

    Article  Google Scholar 

  48. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn’s disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149:916–24.

    Article  CAS  Google Scholar 

  49. Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–9.

    Article  Google Scholar 

  50. Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996–2002. Am J Gastroenterol. 2008;103:1998–2006.

    Article  Google Scholar 

  51. Singh H, Nugent Z, Lix L, Targownik L, Samadder NJ, Bernstein CN. There is no decrease in the mortality from IBD associated colorectal cancers over 25 years: a population based analysis. Gastroenterology. 2016;150:S226–S7.

    Article  Google Scholar 

  52. Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335–42.

    Article  Google Scholar 

  53. Ording AG, Horvath-Puho E, Erichsen R, et al. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn’s disease: a nationwide population-based cohort study. Inflamm Bowel Dis. 2013;19:800–5.

    Article  Google Scholar 

  54. Watanabe T, Ajioka Y, Mitsuyama K, et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology. 2016;151:1122–30.

    Article  Google Scholar 

  55. Watanabe T, Konishi T, Kishimoto J, Kotake K, Muto T, Sugihara K. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011;17:802–8.

    Article  Google Scholar 

  56. Roda G, Narula N, Pinotti R, et al. Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Aliment Pharmacol Ther. 2017;45:1481–92.

    Article  CAS  Google Scholar 

  57. Safroneeva E, Vavricka S, Fournier N, et al. Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients. Aliment Pharmacol Ther. 2015;42:540–8.

    Article  CAS  Google Scholar 

  58. Shanahan F. Relation between colitis and colon cancer. Lancet. 2001;357:246–7.

    Article  CAS  Google Scholar 

  59. Velayos FS, Loftus EV Jr, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology. 2006;130:1941–9.

    Article  Google Scholar 

  60. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451–9.

    Article  Google Scholar 

  61. Rubin DT, Huo D, Kinnucan JA, et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013;11:1601–8.e1–4.

    Article  Google Scholar 

  62. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099–105; quiz 340–1.

    Article  Google Scholar 

  63. Karvellas CJ, Fedorak RN, Hanson J, Wong CK. Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age. Can J Gastroenterol. 2007;21:443–6.

    Article  Google Scholar 

  64. Macdougall IP. The cancer risk in ulcerative colitis. Lancet. 1964;2:655–8.

    Article  CAS  Google Scholar 

  65. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35:1590–2.

    Article  CAS  Google Scholar 

  66. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1988;29:206–17.

    Article  CAS  Google Scholar 

  67. Soderlund S, Granath F, Brostrom O, et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology. 2010;138:1697–703.

    Article  Google Scholar 

  68. Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Cancer morbidity in ulcerative colitis. Gut. 1982;23:490–7.

    Article  CAS  Google Scholar 

  69. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Malignancy in Crohn’s disease. Gut. 1980;21:1024–9.

    Article  CAS  Google Scholar 

  70. Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356–62.

    Article  CAS  Google Scholar 

  71. Nuako KW, Ahlquist DA, Mahoney DW, Schaid DJ, Siems DM, Lindor NM. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology. 1998;115:1079–83.

    Article  CAS  Google Scholar 

  72. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut. 1997;41:522–5.

    Article  CAS  Google Scholar 

  73. Sokol H, Cosnes J, Chazouilleres O, et al. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol. 2008;14:3497–503.

    Article  Google Scholar 

  74. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56:48–54.

    Article  Google Scholar 

  75. Broome U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006;26:31–41.

    Article  Google Scholar 

  76. Aadland E, Schrumpf E, Fausa O, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol. 1987;22:655–64.

    Article  CAS  Google Scholar 

  77. Blackstone MO. An association of fecal bile acids and colon cancer in ulcerative colitis? Gastroenterology. 1988;95:575–6.

    Article  CAS  Google Scholar 

  78. Singh S, Khanna S, Pardi DS, Loftus EV Jr, Talwalkar JA. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2013;19:1631–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology, University of Ottawa, Ottawa, ON, Canada

    Sanjay K. Murthy

  2. The Ottawa Hospital IBD Centre, Ottawa, ON, Canada

    Sanjay K. Murthy

  3. Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Sanjay K. Murthy

  4. School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada

    Sanjay K. Murthy

  5. Department of Medicine, Division of Gastroenterology, University of Toronto, Toronto, ON, Canada

    Geoffrey C. Nguyen

  6. Mount Sinai Hospital IBD Centre, Toronto, ON, Canada

    Geoffrey C. Nguyen

  7. Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada

    Geoffrey C. Nguyen

  8. IC/ES, Toronto, ON, Canada

    Geoffrey C. Nguyen

Authors
  1. Sanjay K. Murthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geoffrey C. Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjay K. Murthy .

Editor information

Editors and Affiliations

  1. Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Joseph D. Feuerstein

  2. Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Adam S. Cheifetz

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Murthy, S.K., Nguyen, G.C. (2019). Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases. In: Feuerstein, J., Cheifetz, A. (eds) Cancer Screening in Inflammatory Bowel Disease . Springer, Cham. https://doi.org/10.1007/978-3-030-15301-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-15301-4_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-15300-7

  • Online ISBN: 978-3-030-15301-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation